Sequoyitol has been shown to ameliorate the progression of DN in HFD-fed plus STZ induced rats through glucose-lowering effects, antioxidant activity, and regulation of TGF-β1 expression [98]. The gene discussed is TGFB1; the disease is liver dysplastic nodule.